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THERAPEUTIC ROLES FOR CARBON MONOXIDE 
IN SUBARACHNOID HEMORRHAGE  
STEPHANIE NOVAS SERVA 
ABSTRACT 
Approximately 1 in 10,000 North Americans have an aneurysmal 
subarachnoid hemorrhage (aSAH) each year. It is a devastating disease with a 
combined morbidity and mortality greater than 50%. Subarachnoid hemorrhage 
(SAH) can lead to neuronal injury and can impair cognitive function by increasing 
pressure on the brain. For these reasons, it is crucial that effective therapies for 
patients suffering from SAH are found. This thesis will discuss the clinical 
characteristics of SAH, as well as possible targets for therapeutic intervention. 
Carbon monoxide (CO) is commonly known as an environmental pollutant 
and toxic diatomic gas, infamous for its extremely high affinity for hemoglobin. 
Research has shown that CO possesses many of the same functions of nitric 
oxide. These functions include vasodilation, inhibition of platelet aggregation, and 
anti-proliferative effects on smooth muscle. It is also known as an anti-
inflammatory agent under specific concentrations and conditions. 
Heme oxygenase isozymes (HO-1 and HO-2) both generate CO in the 
brain following ischemic injury. In ischemic stroke, the function of CO is mediated 
by upregulation of Nuclear factor-erythroid 2-related factor 2 (Nrf2). Nrf2 plays a 
		 v 
protective role in a variety of neurological and inflammatory disorders. 
Experiments have shown that exogenous CO administered to mice with middle 
cerebral artery occlusions results in smaller infarct sizes in the brain compared to 
mice without CO treatment. CO treatment was most effective in its protective role 
after a 1-hour delay in treatment versus a 3-hour delay. Thus, a therapeutic 
window of time in which CO treatment in ischemic stroke is most effective needs 
to be elucidated. The same is true for hemorrhagic stroke. The evidence 
suggests that CO could have a neuroprotective effect following subarachnoid 
hemorrhage by decreasing cerebral inflammation.   
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INTRODUCTION 
 
Anatomy and Physiology of Central Nervous System 
 The brain is surrounded by three meningeal layers. Their primary role is to 
protect the brain and spinal cord. From most superficial to deep, the layers are 
named the dura mater, arachnoid mater, and pia mater. The subarachnoid 
space, or the area between the arachnoid and pia mater, contains cerebrospinal 
fluid (CSF). Many blood vessels also pass through this space. CSF is a filtrate of 
plasma that maintains homeostasis in the CNS.  It also functions as a cushion 
and protects the brain and spinal cord from shocks. CSF is produced mainly by 
the choroid plexus at a rate of 0.2 – 0.7 mL per minute.  Pulsations in the choroid 
plexus and motion of cilia on ependymal cells help the CSF circulate.  CSF is 
absorbed by the arachnoid villi and is then drained back into venous circulation. 
The rate of absorption across the arachnoid villi correlates with CSF pressure. It 
is important that the volume of CSF is controlled, so that intracranial pressure 
(ICP) does not increase to a hazardous level.  This prevents cerebral ischemia or 
lack of blood flow to the brain. 
 
Blood Supply 
 Many cerebral regions are supplied by the Circle of Willis (CoW).  The 
CoW is comprised of the anterior cerebral arteries (ACA), anterior 
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communicating artery, internal carotid arteries (ICA), posterior cerebral arteries 
(PCA), and posterior communicating arteries (Purves et al., 2001). This system 
of arterial supply is redundant. If one artery is blocked, blood can supply the 
same cerebral location by taking a different route. The functional anastomosis is 
a way to prevent brain damage due to cerebral ischemia, or lack of blood supply 
(de Boorder et al., 2006). There are limits to this mechanism, however, and 
significant vessel blockage would still cause cerebral ischemia. The arteries of 
the CoW pass through the subarachnoid space. This allows for exchange of 
material between the CSF and blood vessels. It should be noted that blood does 
not directly enter the subarachnoid space. The middle cerebral arteries (MCA) 
also supply the cerebrum but are not considered part of the CoW. These arteries 
also pass through the subarachnoid space. Blood can enter the subarachnoid 
space due to vessel wall disruption caused by trauma or aneurysm rupture (van 
Gijn et al.,  2007). If this happens, a subarachnoid hemorrhage (SAH) will occur. 
The vessels that are typically involved in SAH are the major arteries of the CoW, 
left or right MCA, or branches of these major arteries (van Gijn et al., 2007). 
There are many pathological consequences of SAH, which will be described in 
later sections. 
Subarachnoid Hemorrhage Definition, Statistics, and Risk Factors 
 
Approximately 1 in 10,000 North Americans have an aneurysmal 
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subarachnoid hemorrhage (aSAH) each year. It is a devastating disease with a 
combined morbidity and mortality greater than 50% (King, 1997). Subarachnoid 
hemorrhage (SAH) can lead to neuronal injury and can impair cognitive function 
by increasing pressure on the brain. In the following paragraphs the clinical 
characteristics of SAH will be discussed, as well as possible targets for 
therapeutic intervention. 
A study in the Chinese Medical (Song, n.d.). surveyed 2564 patients with 
nontraumatic spontaneous SAH (aneurysmal and nonaneurysmal) and 
summarized the clinical characteristics of all SAH patients, as seen in Table 1.  
Patients with aSAH were slightly older than those with non-aneurysmal SAH. The 
study found no significant differences in smoking and drinking history, family 
history of cerebrovascular disease, diabetes or dyslipidemia between the two 
groups. In patients with hypertension, there is a significant difference in the 
number of patients with aneurysmal versus non-aneurysmal SAH.  (Song, n.d.).  
SAH causes the accumulation of blood in the subarachnoid space. The 
extravasated erythrocytes surrounding the bleed contain heme, and the presence 
of heme will eventually lead to cerebral inflammation. A known enzymatic 
pathway is responsible for this inflammation. Heme oxygenase (HO) enzymes 
degrade heme into biliverdin, iron, and carbon monoxide (CO) (Schallner et al., 
2015). HO exists as 2 isoforms. HO-1 is ubiquitously expressed and inducible, 
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while HO-2 is constitutively expressed in the brain, endothelium and testes. HO-1 
expression is significantly upregulated in glial cells following cerebral injury 
(Sutherland et al., 2009). The role of HO-1 in response to cerebral injury is likely 
related to its bioactive products, including CO. Low doses of exogenous CO were 
actually found to substitute for the absence of HO-1 and had protective effects on 
neuronal cells (Schallner et al., 2015). 
 
Table 1: Clinical Characteristics of SAH patients* 
 
*(Song et al., 2017) 
 
One of the bioactive products of HO-1, iron, is hypothesized to cause 
neuronal cell damage via free radicals (LeBlanc et al.,2016). Deferoxamine 
(DFX) is an iron chelating agent that has been shown to have neuroprotective 
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abilities in many hemorrhagic models (Loftspring, 2010). DFX was found to 
produce neuroprotective effects and improve cognitive outcomes by reducing 
cerebral damage after SAH. It was further elucidated that DFX is dependent on 
the present of HO-1 (LeBlanc et al., 2016). ICV DFX treatment after SAH caused 
an increase in HO-1 co-localization to microglia. This effect was abolished in HO-
1(-/-) microglia. DFX produces synergistic effects by increasing CO protection 
and decreasing the toxicity of iron. 
 
Role of Toll-like receptor 4 in Pathogenesis of Subarachnoid Hemorrhage 
It has long been though that microglia and the Toll-like receptor pathway 
play a role in the pathogenesis of aSAH (Hanafy, 2013) It has been found that 
SAH pathology could have different phases (Hanafy, 2013), and that therapies 
often fail because they are not tailored to these specific phases. For example, 
neuronal apoptosis in late phase SAH is characterized by TLR4- toll receptor 
associated activator of interferon (TRIF)-dependence and microglial 
independence (Hanafy, 2013). On the contrary, early phase SAH neuronal 
apoptosis was mostly TLR4-MyD88 and microglial dependent (Hanafy, 2013). 
These results suggest that novel strategies that specifically target TLR signaling 
and microglia at different time points could improve the outcomes for patients 
(Khalid A. Hanafy, 2013).  
  
	6 
Subarachnoid Hemorrhage Clinical Signs, Symptoms, and Diagnosis 
 SAH is usually followed by several clinical manifestations. When blood 
enters the subarachnoid space, there is a failure of the normal physiological 
mechanism to keep the pressure at the correct level around the cerebrum. This 
hemorrhage causes a sudden increase in ICP. Patients will feel a severe 
headache called a “thunderclap headache”, named after its fast onset and 
severity (Rabinstein, 2013). As the hemorrhage progresses, the patient may feel 
confused, nauseous, and may experience seizures (van Gijn et al., 2007). Other 
signs and symptoms include, blurry vision, dizziness and numbness or weakness 
(Mäkitie et al., 2016). Continued cerebral edema or hydrocephalus is common in 
the days following ictus due to blood and excess fluid in the subarachnoid space. 
This excess fluid will cause increased pressure and further brain damage. There 
is a phenomenon known as delayed cerebral vasospasm (DCV) that typically 
occurs 4 to 12 days after ictus (Heros, Zervas, & Varsos, 1983). DCV causes the 
radius of the affected artery to decrease. This constriction causes ischemia and 
hypoxia in the cerebrum and is often the main reason for the many adverse 
events related to SAH (Geraghty et al., 2017). For these reasons, there is 
ongoing research focused on finding therapies to effectively reduce DCV. 
 SAH patients are also known to have fever which tends to have a negative 
impact on patient outcome (Kramer et al., 2017). It has been suggested that 
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fever is associated with DCV in SAH patients, as well as functional disability and 
cognitive impairment (Oliveira-Filho et al., 2001). Fever in SAH is different than 
canonical fevers because there is no infectious agent present in the patient. At 
this point in time, the reason behind this SAH-related fever is unknown, though 
research studies are ongoing. SAH-related fever is currently treated with body 
cooling techniques and antipyretic medication (Scaravilli, Tinchero, Citerio, & 
Participants in the International Multi-Disciplinary Consensus Conference on the 
Critical Care Management of Subarachnoid Hemorrhage, 2011). However, these 
treatment methods are often unsuccessful. Future research is needed to 
elucidate this fever pathway and viable treatment options.  
 There are four types of intracerebral hemorrhage: epidural hematoma, 
subdural hematoma, subarachnoid hemorrhage, and intracerebral hemorrhage. 
They are named for the location of the bleed within the central nervous system. 
Since SAH treatment is different from that of other types of cerebral hemorrhage, 
it is important to determine which type of hemorrhage the patient is having. SAH 
is confirmed by Computed Tomography (CT) or Magnetic Resonance Imaging 
(MRI) scanning techniques.  Lumbar puncture is also used to rule out other 
potential diagnoses (Long et al., 2017). It is crucial to determine the severity of 
the initial bleed because this is the most well-known indicator of SAH outcome. 
Determining the severity of the bleed also helps to establish the degree of 
neurological impairment using an SAH grading system. Commonly used grading 
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scales for SAH include Hunt and Hess Scale, Fisher Scale, Glasgow Coma 
Score (GCS), and World Federation of Neurological Surgeons Scale (Rosen & 
Macdonald, 2005).  The GCS is the most common scoring system used to 
describe the level of consciousness in a patient after traumatic brain injury. The 
GCS measures the eye, verbal, and motor responses of a patient in order to 
establish an overall score which describes their state of consciousness. In 
general, a GCS of 8 or less corresponds to a severe injury, a GCS of 9-12 
corresponds to a moderate injury, and a GCS of 13-15 corresponds to mild brain 
injury.  
 
Subarachnoid Hemorrhage Treatment and Outcome  
 Treatment of SAH varies from patient to patient. Treatment is also 
dependent on the cause of the bleed (traumatic or aneurysmal) and the extent of 
damage to the cerebrum. Patients will often spend 10-15 days in the Neuro-
intensive Care Unit. Patients must be constantly monitored for complications like 
re-bleeds, vasospasm, and hydrocephalus. If the bleed is aneurysmal in nature, 
the physicians may choose to prevent any potential re-bleeds by using 
techniques like surgical clipping or endovascular coiling surgery (Bederson et al., 
2009). Both methods work by isolating the aneurysm from the normal circulation 
so that blood travels via a different route. The difference is in the approach used 
to isolate the aneurysm. In surgical clipping, a titanium clip is placed at the base 
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of the aneurysm. In endovascular coiling, a radiopaque platinum coil is delivered 
through a microcatheter into the aneurysm, and then detached by electrolysis 
(Rinaldo et al.,  2017).  
 Besides surgical intervention, another immediate SAH treatment is 
focused on managing the hydrocephalus and vasospasm. A lumbar drain is 
inserted into the subarachnoid space of the spinal canal or a ventricular drain is 
inserted into the ventricles of the brain (Bederson et al., 2009). These methods 
work to drain excess CSF and blood and ultimately reduce the hydrocephalus. 
There are limited treatment options for vasospasm. Physicians will typically 
monitor for signs of vasospasm using a Transcranial Doppler (TCD). This is an 
ultrasound technique that uses a pulsed Doppler transducer to assess 
intracerebral blood flow (Sarkar et al., 2007). Nimodipine, a calcium channel 
antagonist, can be administered to treat vasospasm (Chowdhury et al., 2013). 
Neurosurgeons may also choose to perform a balloon angioplasty to open the 
affected artery (Andaluz et al., 2002). A balloon angioplasty is a minimally 
invasive, endovascular procedure used to widen narrowed or obstructed arteries 
or veins. 
 SAH treatment extends beyond the time of the ictal event. SAH patients 
will often experience post-ictus complications. The nature of these complications 
depends on the cerebral area that is supplied by the affected vessel. Memory 
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disturbances, executive deficits, delirium, and depression are all possible issues 
that SAH patients can experience. Treatment options include physical therapy, 
occupational therapy, and clinical counseling (Ackermark et al., 2017). 
Unfortunately, overall neurological outcome in most SAH patients is poor and 
further research is required to elucidate effective therapies.  
 
Cells and Biomarkers Involved in Neuroinflammation 
A review of the cells and biomarkers involved in SAH is needed in order to 
fully understand its pathology. The innate immune response is similar in an array 
of CNS pathologies, including but not limited to SAH, intracerebral hemorrhage, 
ischemic stroke, infection, and trauma (Buchanan, Hutchinson, Watkins, & Yin, 
2010). An important event in innate immune response to these CNS conditions is 
the activation of immune cells. These cells produce proinflammatory soluble 
mediators. Microglia and astrocytes are both glial cells that are involved in 
neuroinflammation. Microglia are the resident tissue macrophages of the CNS. 
These cells are responsible for phagocytosying and eliminating microbes and 
dead cells, displaying antigens to adaptive immune cells, secreting inflammatory 
mediators such as TNF-a and Interleukin-1 and initiating tissue repair (Kumar et 
al., 2013).  
Microglia are also responsible for mediating many events in 
neuroinflammation including cytotoxicity, repair, regeneration, and 
immunosuppression (Chhor et al., 2013.). Astrocytes are the most abundant cell 
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type in the cerebrum and make up a significant portion of the blood-brain barrier. 
They help regulate the CNS extracellular environment and act as neuronal 
support cells. During neuroinflammation, astrocytes become activated by signals 
released from microglia (Mayer, 2013). Research suggests that there is a key 
interaction between astrocytes and microglia that is involved in initiating and 
maintaining neuroinflammation in various CNS pathologies (Barbierato et al., 
2013). For example, the astrocyte response to TLR4 was found to be completely 
dependent on functional microglia (Holm, Draeby, & Owens, 2012). Neutrophils 
are another innate immune cell which also engulf and neutralize pathogens. They 
also secrete pro-inflammatory mediators (Kumar et al., 2013) and have been 
shown to play a role in experimental SAH-induced acute lung inflammation 
(Cobelens et al., 2010). However, their role in SAH neuroinflammation is most 
likely minor.  
Until recently, neurons were thought to play a passive role in 
neuroinflammation. Recent research shows that neurons become activated via 
proinflammatory pathways and secrete cytokines such as TNF-a and interleukin-
6. Activated neurons have been shown to increase neutrophil migration across 
the vessel endothelial monolayer by increasing expression of adhesion 
molecules such as ICAM-1 on endothelial cells (Leow-Dyke et al., 2012). Other 
studies have shown that neurons possess protective mechanisms, which 
promote self-survival during the early phase of SAH neuroinflammation (Endo et 
al., 2006). 
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Etiology of Carbon Monoxide Toxicity 
 CO poisoning results in an average of 438 deaths in the United States 
annually (Sircar et al., 2015). CO has an extremely high affinity for hemoglobin. 
In fact, CO binds to hemoglobin with an affinity 220% greater than that of 
oxygen. When CO binds to hemoglobin it forms carboxyhemoglobin. The 
formation of carboxyhemoglobin reduces the oxygen carrying capacity of 
hemoglobin and leads to cellular hypoxia. In addition, the release of oxygen to 
tissues in the body is reduced because the binding affinity for oxygen to 
hemoglobin is increased. Moreover, CO binds to the heme moiety of cytochrome 
c oxidase in the electron transport chain. The binding inhibits mitochondrial 
respiration which causes the intracellular partial pressure of O2 in the tissue to 
decrease to levels below the normal physiological value (Hanley & Patel, 2017).  
 Because CO disrupts oxidative metabolism, it also leads to the formation 
of free radicals which causes cell death, damage, and activation of the immune 
system. (Figure 1). Lipid peroxidation and cellular apoptosis follow the 
hypotension and unconsciousness that occur with CO poisoning (Bleecker, 
2015).  
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Figure 1. Reactive oxygen species formation: a series of cell damaging 
processes is initiated when CO binds to Cytochrome C (CytC) and when it binds 
to nitric oxide forming peroxynitrite (ONOO−). (Roderique et al.,  2015) 
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Literature Review 
Carbon Monoxide Overview 
CO is commonly known as an environmental pollutant and toxic diatomic 
gas, with an extremely high affinity for hemoglobin. Research has shown that CO 
possesses many of the same functions of nitric oxide (NO). These functions 
include vasodilation, neurotransmission, inhibition of platelet aggregation, and 
anti-proliferative effects on smooth muscle. It is also known as an anti-
inflammatory agent under specific concentrations and conditions. CO is a polar 
molecule, but can diffuse into any cell along a concentration gradient without 
requiring a plasma membrane receptor (Hanafy et al., 2001).  
 
Production of Carbon Monoxide via Heme Oxygenase Enzymes 
 CO is produced in the body by heme oxygenases. There are two isoforms 
of heme oxygenase (HO). HO-1 is inducible, while HO-2 is constitutively 
expressed. These metabolic enzymes function to convert heme to ferrous iron, 
biliverdin, and CO, while oxidizing 1 mole of NADPH. Constitutive expression of 
HO-1 occurs primarily in the spleen where it is responsible for metabolizing heme 
coming from senescent erythrocytes. It is also expressed by Kupffer cells in the 
liver and by tissue macrophages. HO-1 expression can also be ubiquitously 
induced under inflammatory conditions, most notably in the brain (Hanafy et al., 
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2001). HO-2 is constitutively expressed in neurons, glial cells, and cerebral 
vasculature (Maines, 1997). HO-2 activation has been shown to involve a 
Ca2+/calmodulin-dependent mechanism by glutamate and ionotropic glutamate 
receptor agonists in the cerebral vasculature (Leffler et al.,). NO binds to a 
regulatory site on HO-2, which can modulate enzyme activity (Ding et al., 1999).  
 
Toxicology of Carbon Monoxide 
 Carboxyhemoglobin is the compound formed when CO binds to 
hemoglobin. The affinity of CO for hemoglobin is 230 times that of oxygen. For 
this reason, inhaling CO will result in ischemia because little oxygen would be 
able to bind to hemoglobin. CO is produced by the incomplete combustion of 
organic matter like gasoline and commonly present in the exhaust of motor 
vehicles, heaters, and cooking equipment. Symptoms of exposure to toxic levels 
of CO include headache, vertigo, and nausea. At a concentration of just 1.3% 
(13,000 ppm), it causes convulsions, respiratory arrest, and death (Watt et al., 
2017).   
Combustion poisoning causes bilateral necrosis of the globus pallidi, a 
major component of the basal ganglia (Kim et al., 2017). There is no question 
that CO is a combustion product and involved in combustion poisoning, however, 
there is little to no evidence suggesting that CO is solely responsible for the 
detrimental effects of combustion poisoning. Many other toxic combustion 
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products are inhaled that are not evaluated for toxicity. In the subsequent 
paragraphs, the evidence that points to CO being a neuroprotective compound 
will be discussed. 
 
Role of Carbon Monoxide in Neurological Disease  
Carbon monoxide has been thought to be a pollutant and neurotoxin with 
lethal effects when inhaled. However, it is now known that CO has many of the 
same functions as nitric oxide (NO). CO can diffuse into any cell along a 
concentration gradient, eliminating the need for a receptor. HO-1 ad HO-2 both 
generate CO in the brain following ischemic injury (Hanafy et al., 2013). In 
ischemic stroke, the function of CO is mediated by upregulation of Nuclear factor-
erythroid 2-related factor 2 (Nrf2) (Hanafy et al., 2013). Nfr2 is a transcription 
factor that binds to response elements on the HO-1 gene promoter. Exogenous 
CO administered to mice with middle cerebral artery occlusions show smaller 
infarct sizes in the brain compared to mice without CO treatment. Nrf2 was found 
to be increasingly localized to the nucleus after treatment with exogenous CO. 
CO treatment was most effective in its protective role after a 1-hour delay in 
treatment versus a 3-hour delay (McCoubrey et al., 1997). Thus, a therapeutic 
window of time in which CO treatment in ischemic stroke is most effective needs 
to be elucidated. The same is true for hemorrhagic stroke. The evidence 
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suggests that CO could have a neuroprotective effect following subarachnoid 
hemorrhage by decreasing cerebral inflammation.  
HO-1 expression in the brain can be induced under inflammatory 
conditions, and HO-2 is constitutively expressed in the brain. Given that CO is a 
main product of both isozymes of HO, it can be said CO is a major regulator of 
the general inflammatory milieu of the brain (Otterbein et al., 2003). Multiple 
sclerosis and stroke, both ischemic and hemorrhagic, are two areas of 
neurological disease that have been well studied with respect to the HO system.  
 
Neuroprotection – intravitreal CO release  
 Research has shown that the intravenously administered CO-releasing 
molecule (CORM) ALF-186 protected retinal ganglion cells (RGC) after ischemia-
reperfusion-injury (IRI) and stimulated axon regeneration in vitro (Stifter et al., 
2017). Retinal neurons, specifically RGC are susceptible to oxygen deprivation. 
Vascular occlusion, ischemic optic neuropathy, and diabetic retinopathy leads to 
hypoxic conditions which causes neurodegeneration. Thus, it is important to 
understand neuroprotective approaches that can also address the known 
stressors involved in neurodegeneration.  
 In this study (Stifter et al., 2017) , researchers used adult male and female 
rats for RGC quantification and molecular analysis, and retinal explants 
Retrograde RGC-labeling was done seven days before IRI. For IRI, the anterior 
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chamber of the left eye was cannulated with a 30-gauge needle connected to a 
reservoir containing 0.9% NaCl. Intraocular pressure was increased and ocular 
ischemia was microscopically confirmed via interruption of retinal circulation. 
ALF-186 was used as a CORM. A CORM is a molecule containing a heavy-metal 
framework that were created as carriers of covalently-bound CO. These 
substances can be administered either orally or intravenously and ensure a 
constant release of CO to organs and tissues in the body. ALF-186 is part of a 
special group of CORMs. It is water-soluble and releases its covalently bound 
CO molecules more slowly when compared to other CORMs.  
To determine the neuroprotective effect of the CO released from ALF-186, 
the rats received 5uL of intravitreal ALF-186, PBS (vehicle control), or inactivated 
ALF-186. Retinal tissues were harvested for analysis of protein expression via 
Western Blot 24 hours after IRI. From the harvested retinal tissue, total RNA 
from ¼ of retina was extracted. Reverse transcription was performed and real 
time polymerase chain reactions (RT-PCR) were done. Relative gene expression 
in IRI injured retinal tissue with either injected substance was calculated in 
relation to the corresponding gene expression in the contralateral non-injured 
retinal tissue of each animal. In other words, the gene expression of the injured 
left eye was measured against that of the non-injured right eye. For RGC 
quantification, retinal tissue of both eyes was harvested seven days after IRI of 
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the left eye. The densities of labeled RGC were determined in a blinded fashion 
using a fluorescent microscope (Stifter et al., 2017) 
Retinal organ cultures were used to evaluate whether CO affects the 
inherent ability of RGC to regrow axons after IRI. The retinal tissue of eyes 
treated with either ALF or inactivated ALF after IRI and the respective 
contralateral eyes were harvested two or seven days after IRI. Right 
homogenous explants/retinae were trepanned and cultured in media. 
Researchers counted the regrowing axons from the retinal explants after six 
days. Explants were labeled and the nuclei of the retinal cells were stained and 
added to embedding medium. The explants were then examined under a 
fluorescence microscope. Beta-III tubulin positive axons that passed a certain 
distance to the explant margin were counted. (Stifter et al., 2017) 
 Researchers in this study found that rats injected with PBS after IRI had a 
remarkable loss of RGC when compared to the RGC density in the contralateral 
unoperated eyes. ALF-186 injected immediately after IRI reduced the extent of 
RGC damage in ischemic eyes. Inactivated ALF-196 did not reduce RGC-death 
(Figure 2) 
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Figure 2. Protection of retinal ganglion cells by intravitreal-administered 
ALF-186 after ischemia-reperfusion-injury. (A) Images of flat mounted retinae 
taken seven days after IRI. The uninjured eye without treatment is shown in the 
left image. Images 2-4 represents the injured left eye after intravitreal injection of 
PBS, ALD-186, or inactivated ALF-186. A significant reduction of RGC-density 
was noticeable after IRI when treated with PBS or iALF. ALF protected RGC 
after injury. Scale bar indicates 200 μm. (B) Quantification of RGC-density 
showed protection of RGC after ischemia in the ALF-treated eyes in comparison 
to inactivated ALF or PBS. (Stifter et al., 2017) 
 
 Researchers also found that ALF-186 differentially regulated MAP kinase 
phosphorylation in the retina. Western Blot images showed the suppression of 
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phosphorylated ERK1/2 compared to total ERK1/2 after IRI+ALF-186 treatment. 
In contrast to ERK1/2, the scientists detected an increase in p38 phosphorylation 
after treatment with ALF-186. Treatment with inactivated ALF and PBS 
demonstrated no alteration in p38 phosphorylation. In addition, the researchers 
performed RT-PCR to analyze caspase-3 mRNA expression. Injection of ALF-
186 dramatically decreased mRNA expression after IRI. ALF-186 injection also 
decreased NF-kappaB, a transcription factor involved in inflammation and cell 
death. 
 Overall, this study demonstrated that CORM injection into the vitreous 
body has neuroprotective effects in the context of IRI. Intravitreal ALF-186 
injection reduced RGC loss, which was visualized by a higher RGC density 
compared to PBS or inactivated ALF density. This finding also corresponds to 
the decreased caspase-3 expression in retinae after IRI+ALF compared to 
IRI+iALF or IRI+PBS. This data represents the anti-apoptotic capacity of ALF. 
CO is shown to antagonize neurodegeneration and neuroinflammation in the 
retina and brain. (Stifter et al., 2017) 
 
Low-dose carbon monoxide inhalation protects neuronal cells from apoptosis 
after optic nerve crush  
 In a separate study, researchers hypothesized that low-dose CO 
inhalation can protect RGCs in a rat model of optic nerve crush (ONC) (Chen et 
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al., 2016). ONC was performed to imitate glaucomatous optic damage on adult 
male rats. CO (250ppm) or air was inhaled for 1 hour immediately after ONC. All 
tests were done 2 weeks after ONC. To assess visual function, researchers 
recorded flash visual evoked potentials (FVEP) and pupil light relax (PLR). RGC 
density was measured by hematoxylin and eosin staining along with Fluorogold 
labeling. Retinal apoptotic process was analyzed using TUNEL staining and 
caspase-3 activity measurement (Chen et al., 2016).  
 Researchers found a significant improvement of visual function in CO 
treated ONC rats. The measured FVEP latency was significantly shorter 
compared to untreated rats. As hypothesized, there was a significant difference 
in pupil reflex to light stimulus between the sham group, ONC group, and 
ONC+CO group. PLR amplitude was significantly improved after low-dose CO 
inhalation compared with ONC alone rats. In addition, CO treatment attenuated 
response time of PLR compared to rates subjected to ONC alone (Chen et al., 
2016).   
 CO was also found to enhance the survival of injured RGCs that 
underwent ONC. Fluorochrome FG was used to label RGCs and further confirm 
RGC density. The densities decreased to 41.4% at 2 weeks after ONC. CO 
treatment increased RGC densities by 55.2% (Figure 3) 
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Fig. 3. Measurement of RGC density by FG labeling. Images of flat-mounted 
retina with RGCs labeled with fluorogold at 2 weeks after operation in sham 
group (A), ONC-alone group (B) and ONC + CO group (C), respectively. (D) 
Quantification of FG-labeled RGCs number per mm2. ONC + CO group showed 
a significantly increased FG-labeled RGCs compared with ONC-alone group. 
Scar bar: 50 μm. (Chen et al., 2016) 
 
 Researchers in this study also found that the number of apoptotic cells in 
GCL in the CO treated ONC group was significantly less than the ONC alone 
group.  
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Carbon Monoxide restores circadian rhythm and is neuroprotective 
 In a separate study, researchers hypothesized that oscillations in gene 
expression that control circadian rhythm affect the severity of neuronal injury 
after SAH (Schallner et al., 2017). They also predicted that CO is a main 
contributor to the restoration of circadian rhythm and neuroprotection. To test this 
hypothesis, a murine SAH model was used. Blood was injected at various time 
points of the circadian cycle. After SAH, mice were randomly assigned to receive 
treatment with CO (250 ppm) or air for one hour. Treatment began immediately 
after the SAH surgery and repeated every 24 hours for 7 days. They measured 
circadian clock gene expression, locomotor activity, vasospasm, 
neuroinflammatory markers, and apoptosis. CSF and peripheral blood leukocytes 
from SAH and control patients were also analyzed and measured for clock gene 
expression (Schallner et al., 2017).  
 In this study, researchers looked for patterns in gene expression that were 
indicative of the disruption of normal rhythmicity in SAH patients. They found that 
Per-2 expression in cells from the CSF was significantly higher when compared 
to that of control patients with an unruptured aneurysm. Next, they used Per-2−/− 
mice and analyzed the effect of SAH on circadian-dependent motor activity. 
These knockout mice exhibited a shortened circadian cycle of 22.3 hours. The 
observed circadian period of activity pattern was approximately 30 minutes 
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longer after SAH when compared to pre-SAH activity patterns. Researchers then 
questioned whether the expression of clock genes in the brain and peripheral 
organs would be disrupted after SAH in mice. They found that the expression of 
Per-2 was induced early after SAH when compared with control samples taken at 
the same times. Increased Per-2 expression led to the disruption of central and 
peripheral organ rhythmicity.  
Next, they looked at the effect of various SAH onset times (ZT12 or ZT2) 
on circadian gene expression. ZT refers to Zeitgeber time. When the light-dark 
cycle is 12/12 hours, the starting time of the light period is ZT0 and the starting 
time of the dark period is “ZT12”. The researchers performed both SAH and 
sham operation at one of two times during the circadian cycle and evaluated 
gene expression after seven days. Mice with SAH occurring at ZT12 (peak) 
demonstrated a higher expression of Per-1, Per-2, NPAS-2, and CLOCK in the 
hippocampus and cortex when compared with mice with SAH at ZT2. NPAS-2 
and CLOCK are two transcription factors involved in the circadian rhythm 
feedback loop that are modulated by CO generated by HO-1. By this reasoning, 
researchers further investigated whether HO-1 expression in the brain follows a 
circadian pattern. They found that HO-1 expression in the brain was markedly 
induced at ZT12 compared with ZT2. Moreover, the researchers found that 
increased expression of Per-1, Per-2, NPAS-2, and HO-1 were associated with 
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less neuronal injury and neuroinflammation after SAH. They then wanted to 
determine whether a causative link exists between CO signaling in the brain, 
circadian rhythm gene expression, and SAH-induced neuronal injury. To study 
the role of CO generated in microglia by HO-1, myeloid-specific HO-1 deficient 
mice were used. When compared with gene expression in control mice, the 
expression of the listed genes in HO-1 deficient mice were greatly suppressed. 
Moreover, mice exposed to CO exhibited increased expression of all 4 circadian 
rhythm genes (Figure 4). 
To summarize, this study showed that mice that underwent SAH surgery 
exhibited a disturbance in their molecular and behavioral circadian rhythms. In 
parallel, clock gene expression was disturbed in the CSF of SAH patients. This 
study also showed that endogenous CO generation by HO-1 influences clock 
gene expression and ultimately neuronal injury as measured by changes in 
vasoreactivity, neuronal apoptosis, and myeloid-driven neuroinflammation. 
Furthermore, exogenous CO administration rescued SAH mice, reiterating the 
protection that is seen with increased HO-1 expression. 
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Figure 4. Myeloid heme oxygenase-1 and carbon monoxide modulate 
circadian rhythm gene expression and susceptibility to neuronal injury. A–
D, Expression of Per-1 (A), Per-2 (B), and NPAS-2 (C) in the suprachiasmatic 
nucleus, hippocampus, and cortex in Lyz-Cre-Hmox1fl/fl mice with and without CO 
treatment for 7 days after SAH compared with control animals. (Schallner et al., 
2017) 
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Low Doses of Carbon Monoxide Protect Against Experimental Focal Brain 
Ischemia 
 In a separate study, researchers investigated the protective effects of CO 
on mice after ischemic brain injury (Zeynalov et al., 2009). They subjected mice 
to transient middle cerebral artery occlusion and exposed them to different 
concentrations of CO. They found that low levels of CO protected the brain from 
injury following 90 minutes of transient focal ischemia and 48 hours of 
reperfusion. The total hemispheric infarct volume was significantly reduced when 
inhalation of 125 or 250 ppm CO began at the onset of reperfusion. In addition, 
early exposure to CO limited brain edema formation. Furthermore, neurological 
deficit scores were significantly improved after CO inhalation at 48 hours of 
survival time after ischemia. Transient carboxyhemoglobin levels returned to 
baseline when CO inhalation ceased, suggesting a potential application of CO to 
treat cerebral ischemic stroke (Zeynalov et al., 2009). 
 The scientists induced a transient focal ischemia by a 90-minute occlusion 
of the MCA. They used laser-Doppler flow cytometry to confirm adequate 
occlusion. 87-90% reduction in blood flow was considered adequate. 
Neurological deficit was evaluated after reperfusion and isoflurane anesthesia 
was discontinued. In one cohort, mice were either exposed to normal room air, 
125 ppm, or 250 ppm CO at the onset of reperfusion. In separate cohorts, CO 
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inhalation of 250 ppm was initiated at 1 and 3 hours after reperfusion. Mice were 
then returned to their original cages after the 18-hour exposure. Neurological 
deficit was evaluated again after 24 and 48 hours of reperfusion. Brains were 
then processed for infarct volume and edema analysis. Though small, transient 
increases in carboxyhemoglobin levels were observed, mice exposed to 125 and 
250 ppm CO after MCA occlusion developed significantly less edema and 
smaller cerebral lesions than mice exposed to normal room air. The data suggest 
that inhalation of low doses of CO may be an alternative or adjuvant therapy for 
treating stroke and other ischemic brain injuries, as demonstrated by the lowered 
infarct volume and edema, and improved neurological deficits (Zeynalov & Doré, 
2009) 
 This same research group further studied whether CO might exert its 
neuroprotective effects by modulating the Nrf2 pathway. The transcriptional 
factor Nrf2 is known as a multiorgan protector. It provides neuroprotection by 
binding to antioxidant response elements in order to increase the transcription of 
antioxidant genes (Zeynalov et al., 2009). When cells are subjected to oxidative 
stress, Nrf2 (normally bound to Keap1) dissociates, traverses to the nucleus and 
activates the expression of enzymes like HO-1. In their previous study, the 
researchers found that low doses of exogenous CO can be neuroprotective 
against transient cerebral ischemia (Zeynalov et al., 2009). In this study, their 
goal was to determine whether CO has similar protective effects in permanent 
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focal cerebral ischemia. They also investigated whether CO exerts its protective 
effects by modulating the Nrf2 pathway (Zeynalov et al., 2009). They found that 
the infarct size in mice was significantly reduced when 18 hours of CO inhalation 
began immediately after ischemia (Zeynalov et al., 2009) (Figure 5).  
 
 Figure 5. Inhalation of CO initiated at 0, 1, and 3 h of reperfusion after 
middle cerebral artery occlusion attenuated infarct volume in the: (a) cortex; 
(b) CP complex; and (c) overall hemisphere compared to mice exposed to 
normal air. (d) Representative images of the anterior view of brain slices from 
mice exposed to air, 125 ppm CO, and 250 ppm CO. (e) Inhalation of 125 and 
250 ppm CO initiated at the onset of reperfusion limited brain edema formation in 
the ipsilateral hemisphere compared to air-flow-exposed mice. (f) Effect of CO on 
circulating carboxyhemoglobin. (Zeynalov et al., 2009) 
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In summary, this study demonstrated that low doses of CO could be 
neuroprotective but reducing infarct volume after artery occlusion. These data 
further support a therapeutic role for CO in ischemic brain injury (Zeynalov et al., 
2009) 
 
Microglia regulate blood clearance in subarachnoid hemorrhage by heme 
oxygenase  
 In another study, researchers used a murine model of SAH to 
demonstrate that the expression of HO-1, encoded by Hmox1, in microglia is 
required to reduce vasospasm, neuronal cell death, impaired cognitive function, 
and clearance of cerebral blood burden (Schallner et al., 2015). They also found 
that CO inhalation after SAH surgery reduced injury by enhancing 
erythrophagocytosis and ultimately rescued the absence of HO-1 in microglia 
(Schallner et al., 2015).  
 The researchers first needed to discern the role of HO in neuronal injury 
following SAH. They did this by blocking HO with tin protoporphyrin-IX in wild 
type mice. Cerebral vasospasm, neuronal apoptosis, and cognitive function were 
observed and analyzed over a seven-day period. They found that mice with 
blocked HO function exhibited more severe vasospasm than mice without HO 
inhibition. There was also an increase in neuronal cell death of the dentate gyrus 
and cortex in mice with inhibited HO (Schallner et al., 2015).  
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 The researchers then sought to specifically knock out HO-1 in the 
microglia. Tin protoporphyrin inhibits both isoforms of the enzyme globally. Thus, 
it carries some degree of nonspecificity. To solve this, they generated LyzM-Cre 
Hmox1fl/fl mice. In these mice, HO-1 is specifically knocked out in cells 
expressing lysozyme, including microglia. SAH surgery was then performed on 
these LyzM-Cre Hmox1fl/fl mice as well as control mice. The conditional knock-
out mice showed significantly increased vasospasm, and neuronal apoptosis 
when compared with the control Hmox1fl/fl mice. These results corresponded with 
impaired cognitive function in the LyzM-Cre Hmox1fl/fl mice (Schallner et al., 
2015).  
 To ensure that peripheral myeloid cells were not infiltrating the brain 
following SAH and contributing to the observed effects, the investigators used a 
lead helmet and transplanting bone marrow from Cx3cr1-GFP mice. In order to 
validate the bone marrow transplant, the scientists performed a whole-body 
irradiation in wild-type mice, followed by an infusion of bone marrow cells via the 
penile vein from Cx3cr1-GFP mice. These mice expressed GFP in all cells 
expressing Cx3cr1, including macrophages, monocytes, microglia, neutrophils, 
dendritic cells, and cells of lymphoid lineage. In one group of mice, the head was 
shielded from radiation with a lead helmet. Peripheral blood leukocytes were then 
isolated and analyzed for GFP positivity one week after transplantation. 
Cytospinning and fluorescence microscopy was used to analyze GFP positivity. 
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GFP positivity of the bone marrow was then confirmed by flow cytometry. In a 
separate cohort of mice, SAH was induced 4 weeks after transplantation, as 
described above, to study the effect of SAH on the invasion of bone marrow-
derived cells into the brain, with or without head shielding. Cell invasion into the 
brain was determined 1 week after SAH by fluorescence microscopy. They 
observed no leukocyte infiltration into the brain after irradiation compared with 
transplanted mice irradiated without the helmet. They concluded that head 
shielding prevented compromise of the blood-brain barrier. This method allowed 
for generation of chimeric mice containing peripheral HO-1-competent myeloid 
lineage cells, while still maintaining HO-1 deficient microglia. Head shielding 
prevented cerebral leukocyte infiltration both before and after SAH surgery, 
indicating that infiltration of peripheral myeloid cells into the brain is not involved 
in neuronal injury and inflammation induced by SAH (Schallner et al., 2015).  
 Next, researchers tested whether HO-1 was involved in the clearance of 
blood burden after SAH (Schallner et al., 2015). Using MRI to visualize results, 
LyzM-Cre-Hmox1fl/fl showed 42% greater hematoma volumes compared with 
control mice. This further demonstrates that HO-1 in the microglia is needed to 
eliminate blood and defend against neuroinflammation, neuronal injury, and 
development of neurocognitive effects. With this role for microglial HO-1 
established, the scientists then investigated the role of HO-1 in patients with 
aneurysmal SAH. They measured the expression of HO-1 in the CSF and 
	34 
peripheral blood in 11 patients over time. A time-dependent increase in HO-1 
expression in the CSF was observed, with a peak at 7 days after aneurysm 
rupture. This was not observed in patients with an unruptured aneurysm. HO-1 
expression correlated with the volume of the hematoma, and CSF bilirubin levels. 
Bilirubin levels in the CSF are an indirect marker of the catalytic activity of HO-1 
(Schallner et al., 2015).  
 Given the accrued results, the researchers deduced that a role for 
microglial HO-1 in hematoma resolution could exist (Schallner et al., 2015). 
Primary microglia from LyzM-Cre-Hmox1fl/fl mice and control mice were isolated 
and exposed to fluorescently labeled red blood cells. Phagocytosis of the red 
blood cells was then analyzed by light microscopy. LyzM-Cre-Hmox1fl/fl primary 
microglia showed less phagocytic activity compared with that of control mice.  
 Once the protective role of HO-1 in SAH was established, the researchers 
in this study sought to evaluate whether or not this protective effect could be 
mimicked by exogenous CO inhalation (Schallner et al., 2015). First, they studied 
the effect of CO inhalation on wild type mice after SAH. CO gas exposure was 
started one hour after SAH and repeated every day throughout the length of the 
experiment. Mice treated with exogenous CO exhibited significantly decreased 
vasospasm and neuronal apoptosis in the hippocampus and cortex. In addition, 
spatial memory function was significantly improved after spatial reversal in 
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animals treated with CO. Hematoma volume was also greatly reduced in animals 
treated with CO after SAH compared with that in animals treated with room air. 
They also used a CORM to establish that the observed effects with gaseous CO 
were not dependent on the route of delivery. The CORM, an intravenous 
injection of CO-saturated, pegylated hemoglobin, had similar effects to those 
observed with inhaled CO when compared with control pegylated hemoglobin 
without CO (Schallner et al., 2015) (Figure 6). 
 
 
Figure 6. Exogenous CO gas treatment reduces neuronal injury after SAH 
in WT mice. 
(A) Representative H&E-stained cross sections of the MCA 7 days after SAH in 
WT mice treated with room air or CO. (B) Quantification of MCA vasospasm, 
defined as the quotient of LR and WL. (C and D) Quantification of cleaved 
caspase-3–positive cells per microscopic view in the dentate gyrus for SAH plus 
room air versus SAH plus CO (E) Number of total errors in spatial memory 
function by Barnes maze assessment. Graphs show test results on the days after 
spatial reversal. (F) Total latency in seconds for spatial memory function by 
Barnes maze assessment. (G) Total latency in seconds for spatial memory 
function by Morris water maze assessment. (Schallner et al., 2015) 
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The results obtained in the aforementioned study demonstrate that 
microglial HO-1 is essential in the immune response to SAH by mediating the 
clearance of blood in the subarachnoid space (Schallner et al., 2015). The 
beneficial effects of HO-1 are the elimination of the heme burden at the sight of 
injury, as well as the generation of CO, which regulates erythrophagocytosis. 
This study confirmed that microglia are the principal cell type responsible for the 
elimination of red blood cells after SAH. Moreover, CO produced as a byproduct 
of microglial HO-1 is responsible for preserving neuronal health by increasing the 
phagocytic ability of microglia. This ultimately results in a lowered cerebral heme 
burden (Schallner et al., 2015).  
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DISCUSSION 
Overexposure to CO can have extremely detrimental effects to the central 
nervous system and cardiovascular systems that can be acute (hours to days) or 
delayed (weeks to months) (Weaver et al., 2002). Case reports describe severe 
acute effects of CO poisoning that result in cell death, and brain edema formation 
(Uemura et al., 2001). Exposure to CO can produce blood concentrations of 
COHb greater than 30%, a level shown to cause neurotoxicity (Brunssen etal., 
2003). Therefore, additional studies must be done in order to determine an 
appropriate concentration of CO to be used for neuroprotective purposes after 
ischemic brain injury.  
Overall, an examination of the published findings has shown that low 
doses of CO can be neuroprotective after brain injury. In the study (Stifter et al., 
2017) that examined the neuroprotective effects of intravenously administered 
ALF-186 after IRI, it was found that rats injected with PBS after IRI had a 
remarkable loss of RGC when compared to the RGC density in the contralateral 
unoperated eyes. ALF-186 injected immediately after IRI reduced the extent of 
RGC damage in ischemic eyes. Inactivated ALF-196 did not reduce RGC-death. 
This offers a potential therapeutic role for CO in cases of oxygen deprivation to 
retinal neurons, specifically retinal ganglion cells. Overall, this study 
demonstrated that CORM injection into the vitreous body has neuroprotective 
effects in the context of IRI. Intravitreal ALF-186 injection reduced RGC loss, 
which was visualized by a higher RGC density compared to PBS or inactivated 
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ALF density. 
 Moreover, it was shown that low-dose CO inhalation can protect RGCs 
from glaucomatous optic damage by using an ONC model (Chen et al., 2016).  
As hypothesized, there was a significant difference in pupil reflex to light stimulus 
between the sham group, ONC group, and ONC+CO group.  PLR amplitude was 
significantly improved after low-dose CO inhalation compared with ONC alone 
rats. In addition, CO treatment attenuated response time of PLR compared to 
rates subjected to ONC alone.  CO treatment enhanced the survival of injured 
RGCs after ONC and lowered the number of apoptotic cells in the GCL when 
compared to the untreated group. 
 In the context of circadian rhythm and the severity of neuronal injury after 
SAH, researchers  (Schallner et al., 2017) found that SAH surgery causes a 
disturbance in behavioral and molecular circadian rhythms.  This was observed 
both in murine models and when analyzing the CSF of SAH patients.  The study 
also showed that endogenous CO generation by HO-1 influences clock gene 
expression and ultimately neuronal injury as measured by changes in 
vasoreactivity, neuronal apoptosis, and myeloid-driven neuroinflammation.  
Furthermore, exogenous CO administration rescued SAH mice and increased 
expression of all circadian rhythm genes, further demonstrating the 
neuroprotection that is seen with increased HO-1 expression. 
 Additionally,  it was shown (Zeynalov et al., 2009) that low levels of CO 
protected the brain from injury following 90 minutes of transient focal ischemia 
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and 48 hours of reperfusion.  Furthermore, neurological deficit scores were 
significantly improved after CO inhalation at 48 hours of survival time after 
ischemia.  This study demonstrated that low doses of CO could be 
neuroprotective by reducing infarct volume after artery occlusion.  These data 
further support a therapeutic role for CO in ischemic brain injury. 
Finally, it was shown (Schallner et al., 2015) that the expression of HO-1 
in microglia is required to reduce vasospasm, neuronal cell death, and clearance 
of cerebral blood burden. This research group also found that CO inhalation after 
SAH surgery enhanced phagocytosis of red blood cells and ultimately rescued 
the absence of HO-1 in microglia. This study confirmed that microglia are the 
main cell type responsible for the elimination of red blood cells after SAH. In 
addition, CO produced as a byproduct of microglial HO-1 is responsible for 
increasing the phagocytic ability of microglia. This results in the preservation of 
neuronal health by lowering the cerebral heme burden. 
As seen in the literature cited, low CO doses have been previously 
reported to have anti-inflammatory effects. Exposure to CO has been shown to 
decrease infiltration of macrophages and neutrophils and suppress mobilization 
of the anti-inflammatory cytokine IL-10 (Otterbein, 2002). The neuroprotective 
effect of CO on ischemic injury could also be due to a decrease in cytotoxic or 
vasogenic edema. CO has been reported to have early thrombolytic effects after 
ischemia that could ameliorate survival of endothelial cells. CO is also likely 
helps to preserve vascular integrity responsible for the development of vasogenic 
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brain edema after reperfusion.  
 
  
	41 
CONCLUSION 
An examination of the published findings demonstrates that a therapeutic 
role for CO in subarachnoid hemorrhage exists. In each study, administration of 
low doses of CO preserved overall neuronal health and neurological outcomes. It 
is clear that HO is necessary for the resolution of cerebral hemorrhages and that 
the effects of HO can be rescued in a knockout model by administering low 
doses of CO. Regardless of origin (endogenous or exogenous), the amount and 
exposures of any molecule are crucial to the response of the organism. Low 
amounts of CO have been shown to be therapeutic which have resulted in 
clinical application. A therapeutic role for CO and HO is expanding as research 
into this topic progresses. CO was once viewed solely as a dangerous 
environmental pollutant and is now being explored for its potential roles as a 
gaseous mediator that has roles in decreasing inflammation, neurotransmission, 
and modulating cerebral and systemic hemodynamics. It is not surprising that 
such a multifunctional gas would be studied in numerous neurological diseases 
yielding a variety of effects. More research is needed to determine the 
concentration and time after injury to administer CO for optimal therapeutic 
results. 
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